1. Home
  2. KLTO vs IVP Comparison

KLTO vs IVP Comparison

Compare KLTO & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • IVP
  • Stock Information
  • Founded
  • KLTO 2019
  • IVP 2020
  • Country
  • KLTO United States
  • IVP United States
  • Employees
  • KLTO N/A
  • IVP N/A
  • Industry
  • KLTO
  • IVP Diversified Commercial Services
  • Sector
  • KLTO
  • IVP Miscellaneous
  • Exchange
  • KLTO NYSE
  • IVP Nasdaq
  • Market Cap
  • KLTO 4.8M
  • IVP 7.8M
  • IPO Year
  • KLTO N/A
  • IVP 2023
  • Fundamental
  • Price
  • KLTO $0.16
  • IVP $1.47
  • Analyst Decision
  • KLTO
  • IVP
  • Analyst Count
  • KLTO 0
  • IVP 0
  • Target Price
  • KLTO N/A
  • IVP N/A
  • AVG Volume (30 Days)
  • KLTO 143.5K
  • IVP 30.2K
  • Earning Date
  • KLTO 05-19-2025
  • IVP 05-14-2025
  • Dividend Yield
  • KLTO N/A
  • IVP N/A
  • EPS Growth
  • KLTO N/A
  • IVP N/A
  • EPS
  • KLTO N/A
  • IVP N/A
  • Revenue
  • KLTO N/A
  • IVP $16,592,109.00
  • Revenue This Year
  • KLTO N/A
  • IVP N/A
  • Revenue Next Year
  • KLTO N/A
  • IVP N/A
  • P/E Ratio
  • KLTO N/A
  • IVP N/A
  • Revenue Growth
  • KLTO N/A
  • IVP N/A
  • 52 Week Low
  • KLTO $0.11
  • IVP $1.26
  • 52 Week High
  • KLTO $13.10
  • IVP $401.50
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • IVP 44.36
  • Support Level
  • KLTO N/A
  • IVP $1.47
  • Resistance Level
  • KLTO N/A
  • IVP $1.59
  • Average True Range (ATR)
  • KLTO 0.00
  • IVP 0.12
  • MACD
  • KLTO 0.00
  • IVP 0.02
  • Stochastic Oscillator
  • KLTO 0.00
  • IVP 53.42

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: